Announced Wed, 24 Jun · 12:09 IST
Trading window closed from July 1 ahead of Q1 FY27 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.3%1-day move
₹47.50
prior close
₹48.11
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+6.3+1.1+2.1+6.1+0.0-0.5+6.8+7.4——
Up moveDown movePending
AI summary
Oxygenta Pharmaceutical has closed its trading window from July 1, 2026 until 48 hours after the declaration of Q1 FY27 financial results (quarter ending 30.06.2026). The closure applies to all designated persons, their immediate relatives, and connected persons, as per SEBI insider trading norms. A board meeting will be held separately to consider and approve the quarterly results.
Likely market impact
Routine regulatory compliance filing. Insiders cannot trade during the closed window. Watch for Q1 FY27 results announcement.